Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion: Results from ERCHIVES

Abstract

Background and Aims

We aimed to assess the incidence and progression of chronic kidney disease (CKD) following hepatitis C virus (HCV) seroconversion.

Methods

This retrospective cohort study included Veterans with a confirmed HCV seroconversion between 2001 and 2014 and Veterans with negative HCV testing over the same time period. The outcomes included development of advanced CKD (eGFR < 60 mL/min/1.73 m² on two separate occasions at least 90 days apart, plus a ≥10 mL/min/1.73 m² decline from baseline) and progressive CKD (decline in eGFR of ≥30 mL/min/1.73 m² from baseline). Multivariable Cox proportional hazards models were used to evaluate the association between HCV and incident advanced and progressive CKD.

Results

The final cohort consisted of 71,528 Veterans, including 2589 with recently seroconverted HCV. Over a mean follow-up of 6 years, 36 % of patients with and 31 % without HCV developed advanced CKD (p < 0.001), and 35 % of patients with vs. 26 % without HCV developed progressive CKD (p < 0.001). After controlling for traditional risk factors, recently seroconverted HCV+ patients were significantly less likely to develop advanced CKD (HR 0.86; 95 % CI 0.79, 0.92), and HCV status was not significantly associated with progressive CKD (HR 0.93; 95 % CI 0.86, 1.00). Factors associated with developing advanced and progressive CKD included older age, female sex, diabetes, hypertension, development of cirrhosis, and substance abuse.

Conclusions

In this cohort of newly infected US Veterans, HCV infection was associated with decreased incidence of advanced and unchanged risk of progressive CKD, suggesting a larger role for traditional risk factors in the development of CKD after HCV seroconversion.

from #Esophageal Cancer via a.lsfakia on Inoreader http://ift.tt/1SGaSA9
via IFTTT